• Ganetespib (STA-9090): Unveiling Hsp90 Inhibition in Tumor B

  2026-05-09

  Explore how Ganetespib (STA-9090) advances cancer research through selective Hsp90 chaperone disruption and precise client protein degradation. This article delivers a uniquely mechanistic and translational analysis, highlighting protocol insights and bridging emerging findings to practical assay design.

• Tunicamycin: Applied N-Glycosylation Inhibitor for ER Stress

  2026-05-08

  Tunicamycin enables precise dissection of N-linked glycosylation and ER stress, with robust protocols for both cell and animal models. Leverage APExBIO's high-purity reagent for reproducible inflammation suppression, immune modulation, and glycosylation pathway interrogation.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-05-08

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations, more accurately reflecting the cellular heterogeneity and drug response variability of primary tumors. The model enables detailed investigation of tumor–stroma interactions, drug resistance mechanisms, and personalized therapeutic strategies, advancing preclinical cancer research.

• Dihydrotestosterone (DHT): Protocols and Troubleshooting for

  2026-05-07

  Dihydrotestosterone (DHT) provides robust mechanistic control in androgen receptor signaling and EGFR pathway studies, enabling nuanced interrogation of therapy resistance and neurodegeneration. This guide distills advanced workflows, real-world troubleshooting, and novel insights from recent research, empowering scientists to maximize the translational impact of DHT assays.

• Dehydroepiandrosterone: Mechanisms and Strategy for Translat

  2026-05-07

  This article explores the mechanistic advances and translational strategies involving Dehydroepiandrosterone (DHEA), focusing on its dual roles as a neuroprotection agent and regulator of granulosa cell proliferation. Grounded in biochemical insights and validated workflows, it provides actionable guidance for translational researchers seeking to leverage DHEA in ovarian and neurodegenerative disease models. The discussion contextualizes APExBIO’s DHEA (SKU B1375) within the evolving competitive and experimental landscape, referencing new integrative research on endoplasmic reticulum stress mitigation in ovarian insufficiency. Distinct from conventional product literature, this piece bridges mechanistic rationale and strategic deployment, ensuring relevance for both bench scientists and translational strategists.

• BMS-777607: A Selective c-Met Inhibitor for Platelet and Can

  2026-05-06

  BMS-777607 empowers researchers to precisely inhibit MET signaling for advanced cancer metastasis models and stem cell differentiation workflows. Its high selectivity and robust in vitro and in vivo performance make it a cornerstone for studies targeting apoptosis, metastasis, and megakaryocyte polyploidization.

• Glucocorticoid Receptor Modulation of Hippocampal CYPs Mitig

  2026-05-06

  This study uncovers that pregnenolone 16α-carbonitrile (PCN) suppresses hippocampal cytochrome P450 enzymes and attenuates phenytoin-induced neurotoxicity via glucocorticoid receptor signaling, independent of PXR. The findings illuminate a previously unrecognized mechanism for neuroprotection in antiepileptic drug therapy, with implications for safer pharmacological interventions.

• SAG: Smoothened Receptor Agonist for Advanced Hedgehog Assay

  2026-05-05

  SAG is a potent Smoothened receptor agonist that enables reliable Hedgehog pathway activation in disease modeling, stem cell maintenance, and neuroprotection research. By leveraging validated workflows and troubleshooting insights, researchers can achieve robust, reproducible outcomes in both basic and translational studies.

• Modeling HSV-1 Latency and Reactivation in Human iPSC Neuron

  2026-05-05

  This study presents a validated protocol for differentiating human inducible pluripotent stem cells into functional sensory neurons capable of supporting latent HSV-1 infection and reactivation. The work offers a scalable, human-relevant platform to investigate the molecular mechanisms of viral latency, overcoming key limitations of animal models.

• FASN Inhibition Sensitizes Tumors to Bcl-2 Family Apoptosis

  2026-05-04

  This study uncovers how inhibiting fatty acid synthase (FASN) heightens mitochondrial apoptotic priming in cancer cells, making them more susceptible to BH3 mimetic Bcl-2 family inhibitors such as ABT-263 (Navitoclax). The work clarifies a key metabolic-apoptotic link and suggests new therapeutic strategies for resistant tumors.

• Clozapine in Prefrontal Circuitry: Mechanistic Insights for

  2026-05-04

  Explore how Clozapine, an atypical antipsychotic medication, uniquely modulates prefrontal cortical circuits and ERK1/2 signaling in advanced schizophrenia research. This in-depth review integrates recent molecular psychiatry breakthroughs and practical assay guidance.

• Tunicamycin in Advanced ER Stress Research: Beyond Inflammat

  2026-05-03

  Explore the unique applications of Tunicamycin as a potent N-glycosylation inhibitor, with a special focus on its role in endoplasmic reticulum stress modulation and stem cell mobilization. This article delivers an in-depth scientific analysis and practical guidance for assay design.

• hiPSC-Derived Intestinal Organoids Advance Pharmacokinetic M

  2026-05-02

  This study introduces a direct 3D culture protocol to generate human induced pluripotent stem cell (hiPSC)-derived intestinal organoids (IOs) with robust self-renewal and differentiation capacities. The resulting model demonstrates mature enterocyte function, enabling more reliable in vitro pharmacokinetic research compared to conventional animal and Caco-2 cell models.

• FH1 Small Molecule: Advancing iPS Cell Differentiation to He

  2026-05-01

  FH1 (Catalog No. B3700) uniquely accelerates the maturation and function of iPS-derived hepatocyte-like cells, doubling albumin secretion and enhancing CYP3A4 activity. This article delivers actionable workflow enhancements, troubleshooting insights, and the latest optogenetic gene control advances for liver cell culture research.

• Pharmacokinetic Variability of CSBTA in MASH: Tissue Distrib

  2026-05-01

  This study investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a mouse model. By dissecting the roles of hepatic metabolism and transporter expression, the work provides mechanistic guidance for optimizing dosing strategies in MASH-related pharmacotherapy.

15710 records 1/1048 page Next 12345 下5页 Last page